Apellis Pharmaceuticals, Inc. (APLS) vs BridgeBio Pharma, Inc. (BBIO)
Detailed comparison between Apellis Pharmaceuticals, Inc., BridgeBio Pharma, Inc..Total Return (%)
Apellis Pharmaceuticals, Inc. (APLS)BridgeBio Pharma, Inc. (BBIO)
Which stock do you think will perform better?
Apellis Pharmaceuticals, Inc.
APLS
BridgeBio Pharma, Inc.
BBIO
| Metric | Apellis Pharmaceuticals, Inc. (APLS) | BridgeBio Pharma, Inc. (BBIO) |
|---|---|---|
| Current Price | $22.65 | $51.96 |
| Change | 0.28 (1.25%) | 1.91 (3.82%) |
| Market Cap | $2.86B | $9.93B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -26.96 | -16.98 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $35.72 | $54.60 |
| 52-Week Low | $16.10 | $21.72 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.85 | $-4.29 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| APLS | -19.60% | -21.92% | -18.35% | -28.71% | 61.44% | 61.44% |
| BBIO | 3.92% | 51.89% | 109.52% | 31.21% | 88.60% | 88.60% |